Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
---|
06/08/2006 | WO2006059149A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
06/08/2006 | WO2006059103A2 Pyridine based compounds useful as intermediates for pharmaceutical or agricultural end-products |
06/08/2006 | WO2006058752A1 [1,2,4]triazolo[4,3-a]pyridine derivatives for the treatment of hyperproliferative diseases |
06/08/2006 | WO2006058628A2 Substituted benzoquinolizines as dpp-iv inhibitors for the treatment of diabetes |
06/08/2006 | WO2006058546A1 Novel lactame derivatives as renin inhibitors |
06/08/2006 | WO2006040451A3 Novel 9h-pyrido[2,3-b]indole derivatives serving as cdk and gsk3 inhibitors, method for the preparation thereof, and the pharmaceutical compositions containing such compounds |
06/08/2006 | WO2006027474A3 Novel imidazopyridine derivatives having an affinity with respect to melatonin receptors, method for the preparation thereof and pharmaceutical compositions containing said derivatives |
06/08/2006 | WO2006019940A3 Pyrrolo(oxo)quinolines as 5ht ligands |
06/08/2006 | WO2005120505A3 Tetrahydropyranyl cyclopentyl tetrahy-dropyridopyridine modulators of chemokine receptor activity |
06/08/2006 | WO2003077857A3 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors |
06/08/2006 | US20060122392 Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
06/08/2006 | US20060122390 Boronic ester and acid compounds, synthesis and uses |
06/08/2006 | US20060122245 Novel inhibitors of IMPDH enzyme |
06/08/2006 | US20060122224 Quinoline and quinoxaline compounds |
06/08/2006 | US20060122216 The enantiomer of tenatoprazole and the use thereof in therapy |
06/08/2006 | US20060122215 Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-C]pyridine derivatives for the treatment of obesity |
06/08/2006 | US20060122213 Azaindoles useful as inhibitors of protein kinases |
06/08/2006 | US20060122212 Bicyclic heteroaromatic compounds as kinase inhibitors |
06/08/2006 | US20060122211 HIV integrase inhibitors, pharmaceutical compositions and methods for their use |
06/08/2006 | US20060122210 Inhibitors of 11-beta hydroxyl steroid dehydrogenase type I and methods of using the same |
06/08/2006 | US20060122185 Bicyclic inhibitors of Rho kinase |
06/08/2006 | US20060122172 Novel 1,4-diazabicycloalkane derivatives, their preparation and use |
06/08/2006 | US20060122171 5-[(1-Ethylpiperidin-4-yl)amino]-3-[(3-fluorophenyl)(1H-imidazol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one; antiproliferative agents; modulating cell differentiation,migration, and chemoinvasion; endothelial growth factor-modulated diseases; antiarthritic agents; graft versus host diseases |
06/08/2006 | US20060122166 Chemokine receptors; inhibition of HIV replication; acquired immune deficiency syndrome (AIDS); cis N-(4-{2-[3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]ethyl}-4-phenylcyclohexyl)-1H-pyrazole-4-carboxamide |
06/08/2006 | US20060122061 Arylphenyl-substituted cyclic ketoenols |
06/08/2006 | US20060121308 High luminance, a high external quantum efficiency and a long high temperature driving life at 50 degrees C.; illuminator |
06/08/2006 | CA2610347A1 Alpha-carbolines as cdk-1 inhibitors |
06/08/2006 | CA2588864A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
06/08/2006 | CA2587524A1 Substituted benzoquinolizine derivates |
06/08/2006 | CA2586796A1 [1,2,4]triazolo[4,3-a]pyridine derivatives for the treatment of hyperproliferative diseases |
06/07/2006 | EP1666480A1 Aryl or Heteroaryl Fused Imidazole Compounds as intermediates for Anti-Inflammatory And Analgesic Agents. |
06/07/2006 | EP1666477A1 7-(4-substituted 3- cyclopropylaminomethyl-1- pyrrolidinyl) q uinolonecarboxylic acid derivative |
06/07/2006 | EP1666462A1 N-[1h-indol-5-yl]naphthalene-1-sulphonamide derivatives and related compounds as serotonin 5-ht6 receptor antagonists for the treatment of disorders of the central nervous system |
06/07/2006 | EP1664112A2 Chimeric gabab receptor |
06/07/2006 | EP1664088A2 Hemiasterlin derivatives and uses thereof |
06/07/2006 | EP1664048A2 Process for the preparation of renzapride and intermediates thereof |
06/07/2006 | EP1664047A1 Substituted indolizine 1,2,3,6,7,8 derivatives, fgfs inhibitors, a method for the preparation thereof and pharmaceutical compositions containing said derivatives |
06/07/2006 | EP1664046A1 Aza-quinolinol phosphonate integrase inhibitor compounds |
06/07/2006 | EP1664045A1 Substituted diazabicycloalkane derivatives as ligands at alpha 7 nicotinic acetylcholine receptors |
06/07/2006 | EP1664044A1 S-tenatoprazole sodium monohydrate salt and the use thereof in the form of a proton pump inhibitor |
06/07/2006 | EP1664043A2 Compositions useful as inhibitors of protein kinases |
06/07/2006 | EP1664042A1 IMIDAZO 1,5-a PYRIDINE OR IMIDAZO 1,5-a PIPERIDINE DERIVATIVES AND THEIR USE FOR THE PREPARATION OF MEDICAMENT AGAINST 5-HT2A RECEPTOR-RELATED DISORDERS |
06/07/2006 | EP1664036A1 Benzimidazolone compounds having 5-ht4 receptor agonistic activity |
06/07/2006 | EP1664031A2 Adamantane and azabicyclo-octane and nonane derivatives process of their preparation and their use as dpp-iv inhibitors |
06/07/2006 | EP1664023A1 Sustituted isoquinoline derivatives and methods of use |
06/07/2006 | EP1663994A1 Condensed pyrimidine compounds as inhibitors of voltage-gated ion channels |
06/07/2006 | EP1663975A1 Novel gamma secretase inhibitors |
06/07/2006 | EP1663962A2 Compositions and methods for the treatment of disease associated with trp-p8 expression |
06/07/2006 | EP1663953A1 Inhibitors of histone deacetylase |
06/07/2006 | EP1663238A1 HEXA- AND OCTAHYDRO-PYRIDO[1,2-a] PYRAZINE DERIVATIVES WITH NK1 ANTAGONISTIC ACTIVITY |
06/07/2006 | EP1663237A2 Fused ring heterocycles as potassium channel modulators |
06/07/2006 | EP1663227A2 Dihydropyridine compounds for treating or preventing metabolic disorders |
06/07/2006 | EP1663223A2 Thalidomide analogs as tnf-alpha modulators |
06/07/2006 | EP1663219A2 Use of indole-derived compounds for the preparation of a medicament that can be used to treat diseases related to the splicing process |
06/07/2006 | EP1663204A2 C-kit modulators and methods of use |
06/07/2006 | EP1663202A1 Substituted indoles as inhibitors of poly (adp-ribose) polymerase (parp) |
06/07/2006 | EP1663184A2 Hydantoin derivatives as inhibitors of cellular necrosis |
06/07/2006 | EP1378510B1 Triazaspiro (5.5) undecane derivatives and drugs containing the same as the active ingredient |
06/07/2006 | EP1368355B1 Substituted pyrazolopyrimidines and thiazolopyrimidines |
06/07/2006 | EP1286993B1 Imidazopyridin-8-ones |
06/07/2006 | EP1259489B1 Aryl fused azapolycyclic compounds |
06/07/2006 | EP1164202B1 Mismatch-recognizing molecules |
06/07/2006 | CN1784409A Fused pyrimidine derivatives with CRF activity |
06/07/2006 | CN1784404A Isoquinoline-3-carboxylic acid amides and pharmaceutical uses thereof |
06/07/2006 | CN1784403A Azaindole compounds as kinase inhibitors |
06/07/2006 | CN1784402A Imidazo and thiazolopyridines as JAK3 kinase inhibitors |
06/07/2006 | CN1784401A Novel fused triazolones and the uses thereof |
06/07/2006 | CN1784397A Methyl indoles and methyl pyrrolopyridines as alph-1 adrenergic agonists |
06/07/2006 | CN1784396A P38 inhibitors and methods of use thereof |
06/07/2006 | CN1784380A Novel bioisosteres of actinonin |
06/07/2006 | CN1784231A 1-amino 1H-imidazoquinolines |
06/07/2006 | CN1258533C Antihistaminic spiro compounds |
06/07/2006 | CN1258531C Aminomethyl pyrrolidine derivatives having aromatic substituents |
06/06/2006 | US7057047 reacting 2-diaminopyridine with malic/sulfuric acid to form 2-amino-7-hydroxy-1,8-naphthyridine sulfuric acid salt, reacting in solvent to form phthalimidyl naphthyridine, chlorinating, reducing to hydroxyindolinone, then reacting with 5-methyl-2-oxo-hexyltriphenylphosphonium halide to form racemate |
06/06/2006 | US7057046 Lactam glycogen phosphorylase inhibitors and method of use |
06/06/2006 | US7057042 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction |
06/06/2006 | US7057039 Method for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor in a patient in need thereof which comprises providing to said patient a therapeutically effective amount of a compound of formula I |
06/06/2006 | US7056944 Pyrazole compositions useful as inhibitors of erk |
06/06/2006 | US7056937 Sulfonylquinoxalone derivatives as bradykinin antagonists |
06/06/2006 | US7056917 Prevent drug resistance |
06/06/2006 | US7056911 for example, N-[(2,4-diaminopteridin-6-yl)methyl]-9,10-dihydrodibenz[b,f]azepine; may be useful for treatment or prophylaxis of diseases associated with parasitic infection such as pneumocystis pneumonia, toxoplasmosis, cryptosporidiosis, leischmaniasis and malaria |
06/06/2006 | US7056909 5,5-Difluoro-3(S)-(pyrimidin-5-yl)-9-(5,6,7,8-tetrahydro-(1, 8)-naphthyridin-2-yl)-nonanoic acid; inhibition of bone resorption, restenosis, angiogenesis, retinopathy, macular degeneration, arthritis, metastatic tumor growth, etc. |
06/06/2006 | CA2277951C Imino-aza-anthracyclinone derivatives |
06/06/2006 | CA2199468C 1,2,3,4-tetrahydroquinoxalinedione derivative |
06/06/2006 | CA2178974C Naphthalene derivatives, processes for the preparation thereof, and intermediates therefor |
06/06/2006 | CA2160366C Risperidone pamoate |
06/06/2006 | CA2145514C Process for the preparation of 9-amino camptothecin |
06/01/2006 | WO2006058303A2 Modulators of muscarinic receptors |
06/01/2006 | WO2006058080A1 Treatment of inflammatory bowel disease |
06/01/2006 | WO2006058064A2 Fused aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
06/01/2006 | WO2006057983A1 Macrocyclic aminopyridyl beta-secretase inhibitors for the treatment of alzheimer's disease |
06/01/2006 | WO2006057270A1 Nitrogeneous tricyclic compound |
06/01/2006 | WO2006056863A1 Pyrido’2, 3-d!pyrimidines as anti-inflammatory agents |
06/01/2006 | WO2006056696A2 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof |
06/01/2006 | WO2006056108A1 Nitromethylene derivatives and their use |
06/01/2006 | WO2006056081A1 Method for preparing hexahydro-8-hydroxy-2,6-methano-2h-chinolizin-3(4h)-one esters |
06/01/2006 | WO2006038923A3 Aryl substituted imidazonaphthyridines |
06/01/2006 | WO2006031929A3 Thiazolopyridine kinase inhibitors |
06/01/2006 | WO2006005725A3 N containing condensed heterocycles with antitumor effects |
06/01/2006 | WO2005095399A3 Novel pyrrolo (2,3-b)pyridine derivatives, the preparation and the pharmaceutical use thereof in the form of kinase inhibitors |